Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar;49(5):1507-1517.
doi: 10.1007/s00266-024-04499-9. Epub 2024 Nov 26.

Injectable Poly-L-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations

Affiliations
Review

Injectable Poly-L-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations

Alessandra Haddad et al. Aesthetic Plast Surg. 2025 Mar.

Abstract

Non-facial (body) rejuvenation is a treatment of increasing demand, with patients seeking to harmonize the benefits of rejuvenated facial appearance with other areas of the body. Poly-L-lactic acid (PLLA)-SCA (Sculptra®) has been approved for facial aesthetic uses since 1999 in Europe and since 2009 in the USA and more recently evaluated for the treatment of cellulite of the buttocks and thighs and other body indications. The current evidence base consists largely of prospective observational analyses and case series although systematic evaluations for a number of body areas are underway. Current data support a potential benefit for the use of PLLA-SCA for the aesthetic treatment of the neck, knees, abdomen, hands and upper arms. Improvements in aesthetic appearance (e.g. sagging, wrinkling, dimpling, cellulite) that are sustained over time with minimal side effects can be achieved. Standardization of injection protocols for different body areas is now needed along with the validation of clinical tools that can be used to agree on treatment goals and to evaluate aesthetic improvements over time. A group of international experts in the fields of facial and body aesthetics, plastic surgery and dermatology were selected based on their educational, scientific and publication merits together with clinical experience using PLLA-SCA for body rejuvenation. Here, we provide an evidence-based and expert-led consensus (14 years of off-face treatment experience) on recommendations for appropriate injection protocols for different body sites and evaluation tools when using the biostimulator PLLA-SCA for body aesthetic and rejuvenation procedures.Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Keywords: Biostimulator; Body aesthetics; Body rejuvenation; PLLA-SCA; Poly-l-lactic acid.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: AH is a speaker, trainer, consultant and clinical trial investigator for Galderma. LA is a speaker, trainer, consultant and clinical trial investigator for Galderma. SGF is a consultant, investigator and speaker for Galderma, Allergan, Merz and Revance. JS is a speaker and advisor for Galderma. MSom is a speaker, trainer, clinical trial investigator, consultant for Galderma and Merz. DD’AC is a consultant, investigator and speaker for Galderma, Allergan and IBSA. MP has conducted research and/or served as an advisory board member, speaker, and/or trainer at Endo Aesthetics, BTL Industries, Allergan, Galderma, Merz Pharma, Lumenis, EltaMD, and Revision. KKD is a speaker, trainer, consultant, and investigator for Galderma. MS is a speaker and consultant for Galderma. RVB is a speaker, trainer, consultant and clinical trial investigator for Galderma. LH is a speaker, trainer, consultant for Galderma. KMB is a speaker, trainer, clinical investigator and consultant for Galderma. JH is a consultant and speaker for Galderma and a speaker for Merz. RF is a speaker, trainer and consultant for Galderma, and consultant for Allergan and Merz. DH is a speaker, consultant and researcher for Galderma and a speaker for Merz. CM is an employee of Galderma. FW is an employee of Galderma. IP is an employee of Galderma. DB is an employee of Galderma. Ethical Approval: This article does not contain any studies with human participants or animals performed by any of the authors. Informed Consent: For this type of study, informed consent is not required.

Figures

Fig. 1
Fig. 1
Before and after treatment with PLLA-SCA in the neck region using 1 vial of PLLA-SCA. Pictures courtesy of Dr Walter Loureiro
Fig. 2
Fig. 2
Before and after treatment with PLLA-SCA in the décolletage area using 2 vials of PLLA-SCA. Pictures courtesy of Dr Luddi Oliveira
Fig. 3
Fig. 3
Suggested target areas and distribution of PLLA-SCA injection for gluteal aesthetic treatments
Fig. 4
Fig. 4
Before and after treatment with PLLA-SCA in the knee area using 0.5 vial of PLLA-SCA per side. Pictures courtesy of Dr Luiz Avelar
Fig. 5
Fig. 5
Before and after treatment with PLLA-SCA in the abdominal region using 3 vials of PLLA-SCA. Pictures courtesy of Dr Luiz Avelar
Fig. 6
Fig. 6
Before and after treatment with PLLA-SCA in the hands using 0.5 vial of PLLA-SCA per side. Pictures courtesy of Dr Walter Loureiro
Fig. 7
Fig. 7
Before and after treatment with PLLA-SCA in the upper arm using 3 vials of PLLA-SCA over 3 sessions. Pictures courtesy of Dr Luiz Avelar
Fig. 8
Fig. 8
Before and after treatment with PLLA-SCA in the upper arm using 3 vials of PLLA-SCA over 3 sessions. Pictures courtesy of Dr Luiz Avelar

References

    1. International Society of Aesthetic Plastic Surgery (2022) ISAPS international survey on aesthetic/cosmetic procedures, 2022. Available at: www.isaps.org. [Accessed May 2024.]
    1. Ramirez SPB, Scherz G, Smith H (2021) Characteristics of patients seeking and proceeding with non-surgical facial aesthetic procedures. Clin Cosmet Investig Dermatol 14:197–207 - PMC - PubMed
    1. The Aesthetic Society (2024) Aesthetic plastic surgery national databank statistics, 2020–2021. Available at: www.theaestheticsociety.org. Accessed May 2024.
    1. Wang JV, Akinitilo L, Geronemus RG (2020) Growth of cosmetic procedures in millennials: a 4.5-year clinical review. J Cosmet Dermatol 19:3210–3212 - PubMed
    1. Wat H, Wu DC, Goldman MP (2018) Noninvasive body contouring: a male perspective. Dermatol Clin 36:49–55 - PubMed

LinkOut - more resources